Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry

Dose tapering strategies with biologics in psoriasis may lower the treatment burden over time, while enabling high therapeutic response maintenance in patients benefiting from them. Our results should contribute to developing clinical guidelines to fill the current gap in knowledge on this promising therapeutic approach

Automated summary

Tapering strategies with biologics in psoriasis can reduce treatment burden and maintain therapeutic response. This research contributes to developing clinical guidelines for the promising therapeutic approach, addressing the existing knowledge gap.